Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-022434

Chief Financial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
FRATES JAMES M Chief Financial Officer 2024-02-26 Grant or award +40,000 152,035 D
Derivatives
FRATES JAMES M Chief Financial Officer 2024-02-26 Grant or award · Stock Option (right to buy) +60,000 60,000 D
Loading xslF345X05/ownership.xml…